Genetic Insights into Gastroesophageal Cancer by SMARCA4 Mutations
Dr. Jaffer Ajani's team found that SMARCA4 mutations in gastroesophageal adenocarcinoma did not change patient survival but were linked to particular tumor subtypes, PD-L1 status and other gene mutations.